...
首页> 外文期刊>Brain research >Electro-acupuncture preconditioning abrogates the elevation of c-Fos and c-Jun expression in neonatal hypoxic-ischemic rat brains induced by glibenclamide, an ATP-sensitive potassium channel blocker.
【24h】

Electro-acupuncture preconditioning abrogates the elevation of c-Fos and c-Jun expression in neonatal hypoxic-ischemic rat brains induced by glibenclamide, an ATP-sensitive potassium channel blocker.

机译:电针预处理可以消除格列本脲(一种ATP敏感性钾通道阻滞剂)诱导的新生鼠缺氧缺血大鼠大脑中c-Fos和c-Jun表达的升高。

获取原文
获取原文并翻译 | 示例
           

摘要

This study aimed to clarify the neuroprotective mechanism of electro-acupuncture (EA) preconditioning on hypoxic-ischemic brain injury (HIBI). Using Western blot, the expression of c-fos protein (c-Fos) and c-jun protein (c-Jun) induced by glibenclamide, an ATP-sensitive potassium (K(ATP)) channel blocker was examined from cerebral cortical and hippocampal samples in neonatal hypoxic-ischemic rats, with or without EA preconditioning. EA was performed on Hegu (LI4), a well-known acupoint commonly used in Oriental medicine for the treatment of neuronal injury resulting from hypoxia-ischemia (HI). Preconditioned rats were treated with either diazoxide, a K(ATP) channel opener, glibenclamide, or sterile saline injected into the left lateral ventricle (i.c.v.), with or without EA administration before HI insult. Interestingly, low c-Fos and c-Jun expressions were found both in diazoxide and EA groups, 24 h after HI. Furthermore, significant differences in relative optical density (ROD) were found between glibenclamide and HI control groups (P< or =0.05), as well as between the group administered glibenclamide after EA and the HI control group (P< or =0.05). However, the level of c-Fos and c-Jun expression in the group administered glibenclamide after EA was significantly lower than in the glibenclamide group (P< or =0.05). The present findings indicate that the effectiveness of EA preconditioning against HIBI may be mediated via the opening of K(ATP) channels.
机译:这项研究旨在阐明电针(EA)预处理对缺氧缺血性脑损伤(HIBI)的神经保护机制。使用蛋白质印迹法,从大脑皮层和海马体中检测了格列本脲(一种ATP敏感性钾(K(ATP))通道阻滞剂)诱导的c-fos蛋白(c-Fos)和c-jun蛋白(c-Jun)的表达。新生儿缺氧缺血大鼠的样本,有或没有EA预处理。 EA在Hegu(LI4)上进行,Hegu是东方医学常用的穴位,用于治疗由缺氧缺血(HI)引起的神经元损伤。在HI损伤前,先用二氮嗪,K(ATP)通道开放剂,格列本脲或无菌生理盐水处理预适应的大鼠,然后将其注射到左心室(i.c.v.)中,同时使用或不使用EA。有趣的是,HI后24小时,在二氮嗪和EA组中均发现了低c-Fos和c-Jun表达。此外,发现格列本脲和HI对照组之间的相对光密度(ROD)有显着差异(P <或= 0.05),以及EA后给予格列本脲的组与HI对照组之间的相对光密度(P <或= 0.05)。但是,EA后给予格列本脲组的c-Fos和c-Jun表达水平显着低于格列本脲组(P <或= 0.05)。目前的发现表明,EA对HIBI的预处理效果可能是通过K(ATP)通道的开放来介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号